GO:0004479 methionyl-tRNA formyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004479 describes the enzymatic activity that converts L-methionyl-tRNA to N-formylmethionyl-tRNA using 10-formyltetrahydrofolate as the formyl donor.
• The enzyme, encoded by MTFMT in humans and fmt in bacteria, is essential for initiating protein synthesis in mitochondria and bacteria.
• Loss of MTFMT function causes mitochondrial translation defects and has been linked to Leigh syndrome and other mitochondrial diseases.
• Methionyl-tRNA formyltransferase (MTF) is structurally related to glycinamide ribonucleotide formyltransferase and shares a common catalytic fold.
• In mice, Mftmt deficiency alleviates metaflammation by modulating mitochondrial activity, revealing a role in metabolic inflammation.
• Research on GO:0004479 employs knockout, point-mutation, and overexpression models, often combined with Ribo-seq and proteomics to assess translation fidelity.
Description
Methionyl-tRNA formyltransferase activity (GO:0004479) is a fundamental molecular function that catalyzes the formylation of methionyl-tRNA, a critical step for the initiation of protein synthesis in bacteria and mitochondria. This activity ensures that the initiator tRNA carries a formyl group, which is required for proper recognition by initiation factors and ribosomal subunits. The enzyme responsible, methionyl-tRNA formyltransferase (MTF), is conserved from bacteria to humans and is encoded by the fmt gene in Escherichia coli and MTFMT in humans. Researchers study GO:0004479 to understand translation initiation mechanisms, mitochondrial gene expression, and the molecular basis of related diseases. Defects in this activity lead to impaired mitochondrial translation and have been associated with Leigh syndrome and other mitochondrial disorders. Moreover, recent studies in mice suggest that Mftmt deficiency can modulate metaflammation, highlighting broader physiological roles.
methionyl-tRNA formyltransferase activity At A Glance
| GO ID | GO:0004479 |
|---|---|
| GO term | methionyl-tRNA formyltransferase activity |
| Ontology | molecular_function |
| Synonym | 10-formyltetrahydrofolate:L-methionyl-tRNA N-formyltransferase activity; conversion of met-tRNAf to fmet-tRNA; methionyl-tRNA transformylase activity; N-terminal peptidyl-methionine N-formylation |
| Major function | Formylation of methionyl-tRNA to N-formylmethionyl-tRNA, essential for translation initiation in bacteria and mitochondria |
| Reaction | 10-formyltetrahydrofolate + L-methionyl-tRNA + H2O = tetrahydrofolate + N-formylmethionyl-tRNA |
| Cofactor | 10-formyltetrahydrofolate (formyl donor) |
| Localization | Cytoplasm (bacteria); mitochondria (eukaryotes) |
| Enzyme | Methionyl-tRNA formyltransferase (MTF), encoded by fmt in E. coli and MTFMT in humans |
What Is GO:0004479?
GO:0004479 is defined as the catalysis of the reaction: 10-formyltetrahydrofolate + L-methionyl-tRNA + H2O = tetrahydrofolate + N-formylmethionyl-tRNA. In other words, it is the enzymatic activity that transfers a formyl group from 10-formyltetrahydrofolate to the amino group of methionine attached to the initiator tRNA, producing N-formylmethionyl-tRNA and tetrahydrofolate. This modification is essential for the initiator tRNA to function in translation initiation in bacteria and mitochondria.
Why Is methionyl-tRNA formyltransferase activity Important in Cell Biology?
Methionyl-tRNA formyltransferase activity is essential for the initiation of protein synthesis in bacteria and in mitochondria, where it ensures that the initiator tRNA is properly formylated for recognition by initiation factor 2 and the ribosome. Without this activity, translation initiation is impaired, leading to defects in oxidative phosphorylation and cellular energy production. In humans, mutations in MTFMT cause mitochondrial translation defects and have been linked to Leigh syndrome and other mitochondrial diseases. Additionally, recent studies in mice have revealed that Mftmt deficiency can alleviate metaflammation by modulating mitochondrial activity, suggesting a role in metabolic inflammation. Thus, understanding GO:0004479 is crucial for basic biology, disease mechanisms, and potential therapeutic interventions.
• Essential for bacterial and mitochondrial translation initiation.
• Required for the formylation of initiator tRNA, a prerequisite for IF2 binding.
• Mutations in human MTFMT cause mitochondrial translation defects and Leigh syndrome.
• Mftmt deficiency in mice modulates metaflammation and mitochondrial activity.
• Target for antibacterial drug development due to its essential role in bacteria.
• Provides insights into the evolution of translation initiation mechanisms.
• Involved in the regulation of mitochondrial energy metabolism.
• Studied using knockout, point-mutation, and overexpression models.
• Biochemical characterization of pathogenic mutations informs genotype-phenotype correlations.
• Potential link to metabolic disorders through mitochondrial dysfunction.
Molecular Mechanism of methionyl-tRNA formyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs the initiator tRNA and the formyl donor to start the reaction.
Methionyl-tRNA formyltransferase (MTF) specifically recognizes the initiator methionyl-tRNA (Met-tRNAfMet) and the cofactor 10-formyltetrahydrofolate. The enzyme binds the acceptor stem and anticodon loop of the tRNA, ensuring that only the initiator tRNA is formylated, not the elongator methionyl-tRNA. Structural studies of E. coli MTF reveal a conserved fold that accommodates both substrates in a productive orientation.
Catalytic Transfer of the Formyl Group
In simple terms: The enzyme transfers a formyl group from the donor to the methionine on the tRNA.
The catalytic mechanism involves the nucleophilic attack of the methionyl amino group on the formyl carbon of 10-formyltetrahydrofolate, resulting in the transfer of the formyl group to the methionine moiety and the release of tetrahydrofolate. This reaction is essential for the formation of N-formylmethionyl-tRNA, which is required for translation initiation in bacteria and mitochondria.
Role in Translation Initiation
In simple terms: The formylated tRNA is then used to start protein synthesis.
The product, N-formylmethionyl-tRNA, is specifically recognized by initiation factor 2 (IF2) and delivered to the ribosomal P site, where it pairs with the start codon. This formylation is critical for the discrimination between initiator and elongator tRNAs and for efficient initiation complex formation.
Structural and Evolutionary Conservation
In simple terms: The enzyme's shape is similar to other formyltransferases, showing its ancient origin.
The crystal structure of E. coli MTF reveals a homodimeric arrangement and a fold similar to glycinamide ribonucleotide formyltransferase (GAR transformylase), indicating a common evolutionary origin for formyltransferases. This structural conservation extends to mitochondrial MTFMT, which shares key catalytic residues.
Regulation and Genetic Context
In simple terms: The gene for this enzyme is often controlled together with other related genes.
In E. coli, the fmt gene is co-transcribed with def, encoding peptide deformylase, forming an operon that coordinates the formylation and subsequent deformylation of nascent polypeptides. This genetic organization ensures that the two opposing activities are regulated together, maintaining the balance of N-terminal methionine modification.
Key Genes Involved in GO:0004479 methionyl-tRNA formyltransferase activity
The following genes and proteins are directly involved in methionyl-tRNA formyltransferase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTFMT | Human mitochondrial methionyl-tRNA formyltransferase; catalyzes formylation of mitochondrial Met-tRNA | Mutations cause Leigh syndrome and mitochondrial translation defects |
| fmt | E. coli methionyl-tRNA formyltransferase; essential for bacterial translation initiation | Model for structural and mechanistic studies |
| def | Peptide deformylase; removes formyl group from nascent polypeptides | Co-transcribed with fmt in E. coli operon |
| mtf1 | S. cerevisiae mitochondrial methionyl-tRNA formyltransferase | Gene disruption affects mitochondrial translation |
| IF2 | Initiation factor 2; binds formylated initiator tRNA | Required for translation initiation |
| MetRS | Methionyl-tRNA synthetase; charges tRNA with methionine | Provides substrate for MTF |
| FMT | Alternative name for methionyl-tRNA formyltransferase in bacteria | Target for antibacterial development |
| GART | Glycinamide ribonucleotide transformylase; structurally related | Evolutionary link to MTF |
| Mftmt | Mouse mitochondrial methionyl-tRNA formyltransferase | Knockout alleviates metaflammation |
| tRNAfMet | Initiator tRNA specific for methionine | Substrate for MTF |
| 10-formyltetrahydrofolate | Cofactor providing formyl group | Essential for reaction |
| MTFMT variants | Pathogenic mutations in human MTFMT | Biochemical characterization reveals loss of function |
| Anticodon mutants | Engineered tRNA variants affecting formylation | Study substrate specificity |
| Ribosome | Translational machinery | Requires formylated tRNA for initiation |
| Mitochondrial ribosome | Mitochondrial translation machinery | Defects in MTFMT impair mitochondrial translation |
How Is methionyl-tRNA formyltransferase activity Regulated?
The expression and activity of methionyl-tRNA formyltransferase are regulated at multiple levels. In E. coli, the fmt gene is co-transcribed with def in an operon, ensuring coordinated expression of formylation and deformylation activities. In eukaryotes, MTFMT is a nuclear gene encoding a mitochondrial protein, and its expression may be regulated by mitochondrial biogenesis pathways. Additionally, the availability of the cofactor 10-formyltetrahydrofolate, which is linked to one-carbon metabolism, can influence enzyme activity. However, specific transcriptional regulators of MTFMT remain to be fully elucidated.
methionyl-tRNA formyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTFMT | Leigh syndrome, mitochondrial translation defect | Patient-derived fibroblasts, MTFMT knockout HeLa cells |
| Mftmt | Metaflammation, mitochondrial activity | Mftmt knockout mouse |
| fmt | Bacterial translation, antibiotic target | E. coli fmt deletion strains |
| mtf1 | Mitochondrial function in yeast | S. cerevisiae mtf1 disruption |
| MTFMT variants | Pathogenic mutations, loss of function | Recombinant expression and biochemical assays |
Leigh Syndrome and Mitochondrial Encephalomyopathy
Mutations in MTFMT cause mitochondrial translation defects and have been identified in patients with Leigh syndrome, a severe neurological disorder characterized by bilateral lesions in the basal ganglia and brainstem. These mutations impair the formylation of mitochondrial initiator tRNA, leading to reduced synthesis of oxidative phosphorylation subunits and energy failure. The clinical presentation includes developmental regression, lactic acidosis, and early death.
Metaflammation and Metabolic Dysregulation
Recent studies in mice have shown that Mftmt deficiency alleviates metaflammation, a chronic low-grade inflammation associated with metabolic disorders, by modulating mitochondrial activity. This suggests that methionyl-tRNA formyltransferase activity may play a role in the interplay between mitochondrial function and inflammatory pathways, offering a potential target for metabolic disease research.
Cancer and Cellular Stress
While direct links between MTFMT and cancer are not well established, mitochondrial translation defects can affect cellular stress responses and apoptosis. Given the role of mitochondria in tumor metabolism, further research may uncover connections between GO:0004479 and cancer biology.
From methionyl-tRNA formyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MTFMT loss on mitochondrial translation? | MTFMT knockout cell lines (e.g., HeLa, HEK293) |
| How do pathogenic MTFMT mutations affect enzyme activity? | Point-mutation knock-in cell lines expressing mutant MTFMT |
| Can MTFMT be targeted for antibacterial therapy? | Bacterial fmt knockout strains and inhibitor screening |
| What is the role of Mftmt in metaflammation? | Mftmt knockout mouse models |
| How does formylation affect tRNA recognition? | Overexpression of MTFMT and mutant tRNAs in E. coli |
| What is the subcellular localization of MTFMT? | Tagged knock-in cell lines with fluorescent reporters |
How to Study the methionyl-tRNA formyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro formyltransferase assay | Enzymatic activity using radiolabeled formyl donor | Characterization of wild-type and mutant MTFMT |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Mechanistic studies of MTF |
| Ribo-seq | Ribosome occupancy and translation efficiency | Assessing mitochondrial translation defects |
| Proteomics | Protein expression levels of OXPHOS subunits | Evaluating mitochondrial function |
| Metabolomics | Levels of 10-formyltetrahydrofolate and related metabolites | Linking one-carbon metabolism to enzyme activity |
| Western blot | Protein expression and modification status | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization of MTFMT | Validating mitochondrial targeting |
| CRISPR screening | Identification of genetic modifiers of MTFMT loss | Uncovering synthetic lethal interactions |
Biochemical Assays for Formyltransferase Activity
Enzymatic activity of methionyl-tRNA formyltransferase can be measured using in vitro assays that monitor the transfer of the formyl group from 10-formyltetrahydrofolate to methionyl-tRNA, often employing radiolabeled substrates or spectrophotometric detection. These assays are essential for characterizing wild-type and mutant enzymes.
Structural Biology and Crystallography
X-ray crystallography and cryo-EM have been used to determine the structure of E. coli MTF and its complexes with substrates, revealing the catalytic mechanism and substrate binding sites. These methods provide a framework for understanding how mutations affect enzyme function.
Ribo-seq and Mitochondrial Translation Profiling
Ribosome profiling (Ribo-seq) can assess the impact of MTFMT loss on mitochondrial translation by mapping ribosome footprints and identifying defects in initiation. This technique is powerful for studying global translation changes in knockout models.
Proteomics and Metabolomics
Mass spectrometry-based proteomics can quantify changes in oxidative phosphorylation subunits, while metabolomics can measure one-carbon metabolites related to 10-formyltetrahydrofolate availability. These approaches link enzyme activity to cellular metabolism.
How CRISPR Can Be Used to Study GO:0004479 methionyl-tRNA formyltransferase activity
Knockout
CRISPR-Cas9 knockout of MTFMT in human cell lines (e.g., HeLa, HEK293) abolishes methionyl-tRNA formyltransferase activity, leading to impaired mitochondrial translation and reduced oxidative phosphorylation. These models are valuable for studying the consequences of loss of function and for testing compensatory pathways.
Point Mutation
Introducing patient-derived point mutations into the endogenous MTFMT locus via CRISPR knock-in allows researchers to study the biochemical and cellular effects of specific pathogenic variants, such as those identified in Leigh syndrome patients. This approach provides insights into genotype-phenotype correlations.
Knock-in
Knock-in of tagged MTFMT (e.g., FLAG or GFP) enables visualization and affinity purification of the enzyme, facilitating studies of its localization, interactions, and dynamics. This is particularly useful for confirming mitochondrial targeting and complex formation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of MTFMT can be used to increase enzyme levels, allowing researchers to study the effects of enhanced formylation on translation and mitochondrial function. Overexpression in E. coli has been used to suppress the effects of tRNA mutations, highlighting the enzyme's role in initiation.
How EDITGENE Supports methionyl-tRNA formyltransferase activity Research
Researchers studying methionyl-tRNA formyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in mitochondrial translation, metabolic regulation, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell and animal models, enabling rigorous functional studies of GO:0004479 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for methionyl-tRNA formyltransferase activity research.
Frequently Asked Questions About methionyl-tRNA formyltransferase activity
What is methionyl-tRNA formyltransferase activity?
It is the enzymatic activity (GO:0004479) that catalyzes the formylation of methionyl-tRNA to N-formylmethionyl-tRNA using 10-formyltetrahydrofolate as the formyl donor, essential for translation initiation in bacteria and mitochondria.
What genes are involved in methionyl-tRNA formyltransferase activity?
The main genes are MTFMT in humans, fmt in E. coli, and mtf1 in S. cerevisiae, which encode the enzyme methionyl-tRNA formyltransferase.
What diseases are associated with MTFMT mutations?
Mutations in MTFMT cause mitochondrial translation defects and have been linked to Leigh syndrome and other mitochondrial disorders.
How is methionyl-tRNA formyltransferase activity regulated?
In E. coli, the fmt gene is co-transcribed with def in an operon, coordinating formylation and deformylation. In eukaryotes, regulation may involve mitochondrial biogenesis and one-carbon metabolism.
What is the reaction catalyzed by methionyl-tRNA formyltransferase?
The enzyme catalyzes: 10-formyltetrahydrofolate + L-methionyl-tRNA + H2O = tetrahydrofolate + N-formylmethionyl-tRNA.
Why is formylation of initiator tRNA important?
Formylation is required for the initiator tRNA to be recognized by initiation factor 2 and to properly assemble the translation initiation complex in bacteria and mitochondria.
Can methionyl-tRNA formyltransferase be targeted for antibiotics?
Yes, because it is essential for bacterial translation and absent in the human cytosol, it is a potential target for antibacterial drug development.
What model systems are used to study methionyl-tRNA formyltransferase activity?
Common models include E. coli fmt mutants, S. cerevisiae mtf1 disruptants, human cell lines with MTFMT knockout or mutations, and Mftmt knockout mice.
What methods measure methionyl-tRNA formyltransferase activity?
In vitro enzymatic assays with radiolabeled substrates, structural biology, Ribo-seq, proteomics, and metabolomics are commonly used.
How does Mftmt deficiency affect metaflammation?
In mice, Mftmt deficiency alleviates metaflammation by modulating mitochondrial activity, suggesting a role in metabolic inflammation.
Conclusion
Methionyl-tRNA formyltransferase activity (GO:0004479) is a conserved and essential molecular function that ensures proper translation initiation in bacteria and mitochondria. Its importance is underscored by human diseases such as Leigh syndrome, caused by MTFMT mutations, and by emerging roles in metabolic inflammation. Researchers can leverage CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with advanced omics methods, to dissect the mechanisms and therapeutic potential of this pathway. EDITGENE offers comprehensive services to support these studies, from model generation to bioinformatics analysis.
References
- 1. Sun X et al.. 2023. Mitochondrial Methionyl-tRNA Formyltransferase Deficiency Alleviates Metaflammation by Modulating Mitochondrial Activity in Mice.. Int J Mol Sci 24(6) PMID: 36983072
- 2. Adam MP et al.. 1993. Nuclear Gene-Encoded Leigh Syndrome Spectrum Overview.. PMID: 26425749
- 3. Vial L et al.. 2003. Mitochondrial methionyl-tRNAfMet formyltransferase from Saccharomyces cerevisiae: gene disruption and tRNA substrate specificity.. Biochemistry 42(4):932-9 PMID: 12549912
- 4. Mayer C et al.. 2003. Anticodon sequence mutants of Escherichia coli initiator tRNA: effects of overproduction of aminoacyl-tRNA synthetases, methionyl-tRNA formyltransferase, and initiation factor 2 on activity in initiation.. Biochemistry 42(17):4787-99 PMID: 12718519
- 5. RajBhandary UL. 1994. Initiator transfer RNAs.. J Bacteriol 176(3):547-52 PMID: 7507918
- 6. Schmitt E et al.. 1996. Structure of crystalline Escherichia coli methionyl-tRNA(f)Met formyltransferase: comparison with glycinamide ribonucleotide formyltransferase.. EMBO J 15(17):4749-58 PMID: 8887566
- 7. Sinha A et al.. 2014. Biochemical characterization of pathogenic mutations in human mitochondrial methionyl-tRNA formyltransferase.. J Biol Chem 289(47):32729-41 PMID: 25288793
- 8. Meinnel T et al.. 1993. Evidence that peptide deformylase and methionyl-tRNA(fMet) formyltransferase are encoded within the same operon in Escherichia coli.. J Bacteriol 175(23):7737-40 PMID: 8244948
